The Mouse Monoclonal anti-Streptococcus Agalactiae antibody has been validated for EIA. It is suitable to detect Streptococcus Agalactiae in samples from Streptococcus agalactiae.
Catalog No. ABIN110696
Quick Overview for Streptococcus Agalactiae antibody (ABIN110696)
Target
Streptococcus Agalactiae
Reactivity
Streptococcus agalactiae
Host
Mouse
Clonality
Monoclonal
Conjugate
This Streptococcus Agalactiae antibody is un-conjugated
ELISA. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
1.0 mg/mL
Buffer
PBS, pH 7.2, 0.09 % Sodium Azide
Preservative
Sodium azide
Precaution of Use
Do Not Add Sodium Azide
Handling Advice
Avoid repeated freezing and thawing. Dilute only prior to immediate use
Storage
4 °C/-20 °C
Storage Comment
Store vial at 2-8 °C prior to restoration. For extended storage add glycerol to 50% and then aliquot contents and freeze at -20 °C or below. Centrifuge product if not completely clear after standing at room temperature. This antibody is stable for one month at 2-8 °C as an undiluted liquid.
Target
Streptococcus Agalactiae
Target Type
Bacteria
Background
Once thought to infect only cows, where it produces mastitis, Streptococcus agalactiae is now known to be able to cause serious disease, bacteremia and meningitis, in immunocompromised individuals and in neonates. Infections in the newborn are the most common and are extremely serious. They are of two types. Early onset of infection, usually occuring within 5 days of birth, is manifested by bacteremia and pneumonia. This infection is contracted vertically, as the baby passes through the birth canal. The other type of infection is a meningitis that occurs between the 10th and 60th days of life. The origin of this infection is not known, but it is not believed to be the mother.